Intravesical Gemcitabine in BCG-Refractory T1G3 Transitional Cell Carcinoma of the Bladder: A Pilot Study

Publisher： Karger

E-ISSN： 1423-0399|76|2|106-111

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.76, Iss.2, 2006-02, pp. : 106-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recurrence and Progression of T1G3 Transitional Cell Carcinoma of the Bladder Treated with Intravesical Bacillus Calmette-Guérin

By  

Urologia Internationalis, Vol. 75, Iss. 2, 2008-07 ,pp. : 107-113

Karger

Access to resources Recommend Favorite

Pharmacokinetic Study of Intravesical Gemcitabine in Carcinoma in situ of the Bladder Refractory to Bacillus Calmette-Guérin Therapy

By  

Urologia Internationalis, Vol. 75, Iss. 4, 2005-12 ,pp. : 309-313

Karger

Access to resources Recommend Favorite

Preliminary Report of a Multicentric Study on Environmental Risk Factors in Ta-T1 Transitional Cell Carcinoma of the Bladder

By  

Urologia Internationalis, Vol. 77, Iss. 2, 2006-08 ,pp. : 152-158

Karger

Access to resources Recommend Favorite

Microstaging of pT1 Transitional Cell Carcinoma of the Bladder

By  

Urologia Internationalis, Vol. 69, Iss. 3, 2002-10 ,pp. : 200-206

Karger

Access to resources Recommend Favorite

Efficacy of Adjuvant Gemcitabine-Cisplatin Chemotherapy: A Comparative Study between Locally Advanced Transitional Cell Carcinoma of the Bladder and Upper Urinary Tract

By  

Urologia Internationalis, Vol. 85, Iss. 1, 2010-03 ,pp. : 47-51

Karger

Access to resources Recommend Favorite